Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

In vitro synergy studies with Clostridium difficile.

A E Bacon1, S McGrath, R Fekety

  • 1Department of Medicine, Medical Center of Delaware, Wilmington 19899.

Antimicrobial Agents and Chemotherapy
|March 1, 1991
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

PAR2 deletion in the osteoblast lineage affords long-term cartilage protection in experimental osteoarthritis.

Osteoarthritis and cartilage·2026
Same author

Safety and Efficacy of Atezolizumab in Combination With nab-Paclitaxel in Patients With PD-L1 Positive Metastatic or Locally Advanced Triple-Negative Breast Cancer: A UK-Wide Cancer Centre Experience.

Clinical oncology (Royal College of Radiologists (Great Britain))·2025
Same author

Periparturient mortality in merino ewes in Australia: Incidence, impact and the path to mitigation strategies.

Australian veterinary journal·2025
Same author

Evaluating the effect of calcium, magnesium and sodium supplementation of Merino ewes on their lambs' growth.

Australian veterinary journal·2023
Same author

Assessment of cannabidiol use in pets according to a national survey in the USA.

The Journal of small animal practice·2023
Same author

Moderate exercise protects against joint disease in a murine model of osteoarthritis.

Frontiers in physiology·2022

The combination of bacitracin and rifampin showed synergistic inhibition against Clostridium difficile. This finding is significant for developing new treatments for C. difficile infections.

Area of Science:

  • Microbiology
  • Infectious Diseases
  • Antimicrobial Resistance

Background:

  • Clostridium difficile is a significant cause of healthcare-associated infections.
  • Effective antimicrobial therapies for C. difficile are crucial due to rising resistance.
  • Understanding synergistic drug combinations can lead to improved treatment strategies.

Purpose of the Study:

  • To evaluate the in vitro susceptibility of Clostridium difficile strains to individual antibiotics and combinations.
  • To identify potential synergistic interactions between rifampin, vancomycin, metronidazole, and bacitracin against C. difficile.

Main Methods:

  • Agar dilution method was employed for anaerobic susceptibility testing.
  • Fifty-five clinical isolates of Clostridium difficile were tested.

Related Experiment Videos

  • Antibiotics tested included rifampin, vancomycin, metronidazole, and bacitracin, individually and in combination.

    • Main Results:

    • Eighty-five percent of tested C. difficile strains (29 of 34) exhibited synergistic inhibition with the combination of bacitracin and rifampin.
    • The fractional inhibitory concentration (FIC) index was used to determine synergy, with values <= 0.50 indicating synergy.

    Conclusions:

    • The combination of bacitracin and rifampin demonstrates significant synergistic activity against Clostridium difficile in vitro.
    • This synergistic effect suggests potential for developing novel therapeutic approaches for C. difficile infections.
    • Further clinical investigation is warranted to explore the efficacy of this drug combination.